Cameron Englman

1 month ago | europeanurology.com | Cameron Englman |Alistair Grey |Francesco Giganti |Busola Adebusoye |Davide Maffei |Vasilis Stavrinides | +10 more

KeywordsActive surveillanceProstate cancerProstate magnetic resonance imagingWhat does this study add? We report the outcomes from a cohort of over 1000 men on magnetic resonance imaging (MRI)-led risk-adapted active surveillance, where one in three men had Gleason 3 + 4 disease and over half had MRI-visible disease.

Mar 30, 2024 | europeanurology.com | Cameron Englman |Clare Allen |Alex P Kirkham

AbstractThe Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) recommendations standardise the reporting of prostate magnetic resonance imaging (MRI) in patients on active surveillance (AS) for prostate cancer. An international consensus group recently updated these recommendations and identified the areas of uncertainty. A panel of 38 experts used the formal RAND/UCLA Appropriateness Method consensus methodology.